Escaping the Hemoglobin A1c-Centric World in Evaluating Diabetes Mellitus Interventions
- PMID: 25697718
- PMCID: PMC4667353
- DOI: 10.1177/1932296815576363
Escaping the Hemoglobin A1c-Centric World in Evaluating Diabetes Mellitus Interventions
Abstract
Any intervention in patients with diabetes must consider its effect on both the incidence of hypoglycemia and hemoglobin A1c. Yet, there is no single metric that expresses these key factors simultaneously. Such a composite metric would permit clinicians, regulators, manufacturers, payers, and researchers to more easily evaluate the merits of an intervention as well as enable the comparison of qualitatively different interventions. This article proposes a composite metric, the hypoglycemia-A1c score (HAS), as the basis for a more comprehensive approach for the stakeholders in diabetes treatment to better understand how an intervention affects diabetes management. The article also demonstrates how additional parameters such as effects on weight, quality of life, and costs could be included in such a scoring system.
Keywords: diabetes mellitus; glycemic control; hemoglobin A1c; hypoglycemia.
© 2015 Diabetes Technology Society.
Conflict of interest statement
References
-
- DCCT. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med. 1993;329:977-986. - PubMed
-
- de Zoysa N, Rogers H, Stadler M, et al. A psychoeducational programme to restore hypoglycemia awareness, the DAFNE-HART pilot study. Diab Care. 2014;37:863-866. - PubMed
-
- Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia. 2002;45(7):937-948. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical